Shareholder Vote

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 24, 2021 Daxor Corporation (Exact name of registrant as specified in its charter) New York 811-22684 13-2682108 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 109 Meco Lane, Oak Ridge, TN 37830 (Address of principal executive offices) (Zip Code) 212-330-8500 Registrant’s telephone number, including area code (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock $0.01 par value DXR NYSE AMERICAN Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [ ] If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ] Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. Item 5.07 Submission of Matters to a Vote of Security Holders The Company’s Annual Meeting was held June 24, 2021. At the Annual Meeting, the following directors were elected for terms expiring at the annual meeting of shareholders to be held in 2022 by the votes indicated: For Withheld Broker Non-votes James Lombard 2,964,273 12,584 387,427 Henry D. Cremisi, MD 2,966,805 10,052 387,427 Edward Feuer 2,967,285 9,572 387,427 Joy Goudie, Esq. 2,966,805 10,052 387,427 Michael Feldschuh 2,898,106 78,751 387,427 Jonathan Feldschuh 2,898,106 78,751 387,427 The following reflects the voting results for matters other than the election of directors brought for vote at the Annual Meeting: For Against Abstain Broker Non-votes Ratification of WithumSmith+Brown, PC as Daxor Corporation’s independent registered public accounting firm 3,354,996 6,033 3,255 0 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. DAXOR CORPORATION (Registrant) Date: June 30, 2021 By: /s/ Robert J. Michel Name: Robert J. Michel Title: Chief Financial Officer 3